Consensus $37.48. “Our strong track record and sustained success, built on operational excellence and disciplined execution, positions us well to advance our strategy and deliver meaningful impact across the healthcare ecosystem,” said Brian Tyler, chief executive officer. “As we continue to strengthen our position and accelerate our strategic priorities, we remain focused on driving sustainable growth and creating long-term value for our shareholders.”
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on MCK:
- McKesson’s Strategic Positioning and Growth Potential Justify Buy Rating
- McKesson announces changes to reportable segments, organizational structure
- McKesson’s Strategic Restructuring and Growth Potential Earns ‘Buy’ Rating from Analyst
- McKesson Announces New Reporting Segments Restructure
- McKesson price target raised to $772 from $766 at Wells Fargo